Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Glatting

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PETH Schirrmeister, A Guhlmann, K Elsner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbsJ Kotzerke, G Glatting, U Seitz, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancerJ Kotzerke, B G Volkmer, G Glatting, et al.
Medical Physics|October 5, 2013
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficientP Kletting, S Schimmel, H A Kestler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancerH Schirrmeister, G Glatting, J Hetzel, et al.
Medical Physics|January 21, 2017
Erratum: "Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient" [Med. Phys. 40, 102504 (2013)]P Kletting, S Schimmel, H A Kestler, et al.
European Journal of Nuclear Medicine|August 16, 2001
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantationS N Reske, D Bunjes, I Buchmann, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 31, 2004
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?G Halter, A K Buck, H Schirrmeister, et al.
Cancer|March 17, 2001
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trialI Buchmann, M Reinhardt, K Elsner, et al.
European Journal of Nuclear Medicine|April 24, 2001
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging proceduresH Schirrmeister, T Kühn, A Guhlmann, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 1999
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PETH Schirrmeister, A Guhlmann, K Elsner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbsJ Kotzerke, G Glatting, U Seitz, et al.
Nuklearmedizin. Nuclear Medicine|February 26, 2003
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancerJ Kotzerke, B G Volkmer, G Glatting, et al.
Medical Physics|October 5, 2013
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficientP Kletting, S Schimmel, H A Kestler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancerH Schirrmeister, G Glatting, J Hetzel, et al.
Medical Physics|January 21, 2017
Erratum: "Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient" [Med. Phys. 40, 102504 (2013)]P Kletting, S Schimmel, H A Kestler, et al.
European Journal of Nuclear Medicine|August 16, 2001
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantationS N Reske, D Bunjes, I Buchmann, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 31, 2004
[18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?G Halter, A K Buck, H Schirrmeister, et al.
Cancer|March 17, 2001
2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trialI Buchmann, M Reinhardt, K Elsner, et al.
European Journal of Nuclear Medicine|April 24, 2001
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging proceduresH Schirrmeister, T Kühn, A Guhlmann, et al.
Pageof 5